The impact of COVID‐19 infection on patients with psoriasis treated with biologics: an Italian experience

Saved in:
Bibliographic Details
Published inClinical and experimental dermatology Vol. 47; no. 12; pp. 2280 - 2282
Main Authors Ruggiero, Angelo, Martora, Fabrizio, Picone, Vincenzo, Potestio, Luca, Camela, Elisa, Battista, Teresa, Fabbrocini, Gabriella, Megna, Matteo
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.12.2022
Subjects
Biological Factors
Biological Products - therapeutic use
COVID-19
Humans
Psoriasis
Psoriasis - complications
Psoriasis - drug therapy
SARS-CoV-2
Online AccessGet full text

Cover

More Information
Bibliography:Conflict of interest: the authors declare that they have no conflict of interest.
Ethics statement. The study was approved by the local Ethics Committee (University of Naples Federico II, Naples, Italy). The patient provided informed consent for publication of their case details and images.
Bakirtzi K
2022; doi
Data availability: data are available on request from the corresponding author.
et al
Clin Exp Dermatol
Funding: none.
Linked article
.
10.1111/ced.15312
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Editorial-2
ObjectType-Commentary-1
content type line 23
ObjectType-Correspondence-1
ISSN:0307-6938
1365-2230
1365-2230
DOI:10.1111/ced.15336